Pharmacology

Action Mechanism of Action Reference
INHIBITOR DNA topoisomerase I inhibitor Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297939
FDA SRS GD2OWY1DTK